Insmed | Costo Del Venduto



Cost Of Sales Cambiamento Data
BioMarin Pharmaceutical USD 136.14M 52.32M 2024-12
Cytokinetics 463K 79.14M 2024-09
Dynavax Technologies USD 13.41M 326K 2024-12
Gilead Sciences USD 1.58B 7M 2024-12
Insmed USD 26.15M 4.98M 2024-12
Novartis USD 3.31B 73M 2024-12
Regeneron Pharmaceuticals USD 565.4M 74.3M 2024-12
Sarepta Therapeutics USD 132.3M 40.61M 2024-12
Ultragenyx Pharmaceutical USD 16.89M 4.13M 2024-12
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



Insmed Costo Del Venduto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.